Indeed, with the view of the ongoing effort to develop drugs that can efficiently target KRAS mutated cancer cells, there are many recent reports that successfully leveraged the ferroptosis machinery to promote cell death in KRAS-driven tumors [73,74,75]. This evidence concerns the gene KRAS and cancer.